Tardive dyskinesia by body region in subjects with schizophrenia/schizoaffective disorder or mood disorder: findings from the KINECT 3 study

被引：0
|
作者：
Factor, S.
Stacy, M.
Burke, J.
Yonan, C.
Le, H.
Liang, G.
机构：
来源：
MOVEMENT DISORDERS | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
408
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Long-Term Effects of Valbenazine on Tardive Dyskinesia in Patients With Schizophrenia/Schizoaffective Disorder or Mood Disorder: Results From an Open-Label, Rollover Study
    Grigoriadis, Dimitri
    Marder, Stephen
    Lindenmayer, Jean-Pierre
    Verghese, Cherian
    Burke, Joshua
    Jimenez, Roland
    Farahamand, Khody
    Siegert, Scott
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S321 - S322
  • [2] Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder
    Nagano, Mieko
    Susuta, Yutaka
    Masui, Hideaki
    Watanabe, Yumi
    Watanabe, Koichiro
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (02) : 107 - 116
  • [3] Preliminary findings of the Gemini-Tardive Dyskinesia study in a population of patients with schizophrenia & poor outcome schizoaffective disorder in Northern Ireland
    Miller, PW
    McCusker, JJ
    McIlroy, S
    O'Neill, FA
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (07): : 803 - 803
  • [4] Preliminary epidemiological findings of a study looking at Tardive Dyskinesia in a population of patients with schizophrenia and poor outcome schizoaffective disorder in Northern Ireland
    Miller, PW
    O'Neill, T
    McCusker, J
    Colgan, G
    Nolan, A
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 105 (07): : 606 - 606
  • [5] Incidence and severity of tardive dyskinesia in patients receiving artpiprazole or haloperidol for the treatment of schizophrenia or schizoaffective disorder
    Sanchez, R.
    Kim, E.
    Eudicone, J.
    Pikalov, A.
    Vester-Blokland, E.
    Miller, D. D.
    EUROPEAN PSYCHIATRY, 2007, 22 : S138 - S138
  • [6] Incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia or schizoaffective disorder
    Miller, Delwyn D.
    Kim, Edward
    Eudicone, James
    Pikalov, Andrei A.
    Vester-Blokland, Estelle
    Coryell, William H.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S123 - S123
  • [7] Incidence of tardive dyskinesia is lower with quetiapine treatment than with typical antipsychotics in patients with schizophrenia and schizoaffective disorder
    Glazer, WM
    Morgenstern, H
    Pultz, JA
    Yeung, PP
    Rak, IW
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 206 - 207
  • [8] Treatment-emergent tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia or schizoaffective disorder
    Miller, D. D.
    Kim, E.
    Eudicone, J.
    Pikalov, A.
    Vester-Blokland, E.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 503 - 503
  • [9] LONG-TERM EFFECTS OF VALBENAZINE ON TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA/SCHIZOAFFECTIVE DISORDER: RESULTS FROM AN OPEN-LABEL, ROLLOVER STUDY
    Kane, John
    Marder, Stephen
    Lindenmayer, Jean-Pierre
    Jimenez, Roland
    Farahmand, Khodayar
    Siegert, Scott
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S199 - S200
  • [10] MOOD-DEPENDENT FLUCTUATIONS IN THE SEVERITY OF TARDIVE-DYSKINESIA AND PSORIASIS-VULGARIS IN A PATIENT WITH SCHIZOAFFECTIVE DISORDER - POSSIBLE ROLE OF MELATONIN
    SANDYK, R
    PARDESHI, R
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1990, 50 (3-4) : 215 - 221
12345